CDK12 and ovarian neoplasm: While this model revealed the impact of Cdk12 loss on ovarian tumor progression, intraperitoneal administration of tumor cells from m-sgPRN;Cdk12KO mice enabled us to further demonstrate the importance of Cdk12 inactivation to tumorigenesis.